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Abstract 
This paper uses an analysis of the treatment of ‘random’ and ‘predictable’ risk in primary 
health care capitation contracts to critique the arrangements in the New Zealand Primary 
Health Care Strategy (NZPHCS) introduced in 2002.  The New Zealand capitation contract 
arrangements are unusual, in that the capitation funder does not meet the full costs of the 
commissioned care, the independent, private sector practitioners receiving capitation 
payments are able to charge the patient for any costs not met by the funder, and the capitation 
incentive becomes increasingly sharp over time as the funder selectively prioritises different 
population groups to receive greater proportions of its subsidies.   
 
The NZPHCS arrangements appear to have assumed away the reallocation of random risk by 
treating the capitation subsidy as a ‘notional averaged treatment subsidy’.  Whilst increased 
government funding has reduced out-of-pocket costs for patients, total system costs have 
undoubtedly risen relative to a fee-for-service counterfactual, with the burden of extra costs 
falling disproportionately on the most frequently ill.  The vulnerable individuals for whom the 
system was supposed to provide greater benefits are also consequently disproportionately 
affected by random shocks that affect the demand for general practitioner services.  The costs 
of shocks such as the waiting list cull are certainly being paid at the GP’s surgery, with the 
sickest paying most of these costs, and the habitually well reaping the benefits.   
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Introduction 
“There are many mechanisms for paying physicians; some are good and some are bad. 
The three worst are fee-for-service, capitation and salary”.             (Robinson, 2001:149)  
 
Recent years have seen the emergence of many health care policies employing risk-sharing 
tools aimed at aligning the activities of service providers with the objectives of purchasers 
and funders.  An example is managed care, where responsibility for managing all aspects of 
the financing and delivery of health care for a defined set of patients is assigned to specific 
care management entities (Robinson, 2004; Rivers and Tsai, 2003).   Whilst managed care 
models involve the use of many non-price elements (e.g. utilisation review), a common 
characteristic is some element of financial risk-sharing (‘supply-side cost-sharing’ – Ellis and 
McGuire, 1986).  
 
The agency theory rationale for supply-side cost-sharing is that by contractually linking the 
care manager’s or care provider’s financial returns to a proxy for the achievement of some 
desired characteristics, or by decoupling financial returns from undesirable characteristics, the 
desired activities will be pursued and the undesirable ones eschewed.  Effort exerted by the 
manager or practitioner, which is unobserved and unobservable by the policy-maker or 
insurance purchaser setting the contract terms, will be redirected towards the pursuit of 
desirable, rather than undesirable, activities (Holmstrom and Milgrom, 1991; Robinson, 
2001).  Commonly-used supply side cost-sharing contracts are price-and-volume, partial and 
full capitation (Danzon, 1997).   
 
Partial or full capitation contracts have become common in primary health care remuneration 
as they reduce the over-consumption externality of subsidised health care by financially 
penalising practitioners who deliver ‘too many’ consultations.  Capitation is the principal 
form of government-funded remuneration for England’s Primary Care Trusts (Keen, Light 
and Mays, 1999), is common in insurance-funded remuneration of primary care physicians in 
the United States (Robinson, 2004; Hagen, 1999) and is the basis of New Zealand’s partially 
tax-funded primary health care strategy (King, 2001).  They are also extensively used in 
public sector ‘outcomes-based’ (Honore, et. al, 2004) and ‘performance-based’ (Martin, 
2002) contracting.  Reduced emphasis on the consultation as the primary payment 
determinant is attributed with a shift in primary care delivery focus away from interventions 
in the event of illness towards the promotion and maintenance of wellness (Coster and 
Gribben, 1999; Cumming, 1999; Malcolm, 1997).  They are also attributed with being stimuli 
for increased equity, targeting of high health need, encouraging a team approach to primary 
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health care, and a change in focus towards a care management model as opposed to a model 
of episodic intervention with a focus on illness (Crampton, Sutton and Foley, 2001).   
 
However, capitation contracts have limitations.  Robinson (2001:4) identifies that capitation is 
inferior to fee-for-service in that it does not recognise the extent of practitioner effort exerted: 
“its payment is determined prospectively without regard to the number of services provided, 
overpaying physicians who stint on care and underpaying those who provide many complex 
services”.  Capitation also performs poorly in regard to risk management, as it is “imperfectly 
adjusted for the severity of illness of each covered patient.  Even a well-adjusted capitation 
payment rate fails to compensate physicians who treat patients whose condition deteriorates, 
leading to greater utilization and cost, for reasons independent of the physician’s own 
actions” (ibid).   Howell (2007) suggests that a high dependence of practitioners’ incomes on 
unpredictable variations in individuals’ demand for services poses particular challenges for 
the use of the instrument in health care markets generally, and primary health care markets in 
particular, that are not present in many other markets.  
 
In section one, this paper explores the effect that random events can have upon practitioners’ 
incomes in capitation contracts generally.  Section two then discusses the particular 
arrangements of the New Zealand Primary Health Care Strategy (NZPHCS) capitation 
contracts introduced in 2002.  The effects of the New Zealand strategy are illustrated in 
section three with two recent ‘random’ events:  a strike by junior doctors in the country’s 
hospitals, and a decision by District Health Boards (DHBs) to remove all individuals on 
waiting lists for secondary and tertiary (hospital-provided) consultations and procedures for 
six months or longer back to their primary care providers for ongoing management.  The 
section also illustrates how other elements of the New Zealand capitation contract, such as the 
requirement that increases in government capitation subsidies be passed on to patients in the 
specific capitation classes as reduced patient payments, and rigorous enforcement of 
practitioner charges to patients may affect sector outcomes.  Section four concludes.  
 
1. Capitation in Primary Health Care Markets 
In a partial capitation contract, the remunerated party’s income comprises a fixed component f 
determined by the ex-ante characteristics of the population for whom care responsibility is 
assumed, and a variable component v for each unit of output q produced at a cost c (profit = f-
q(c-v)).  In a full capitation contract (v = 0), the recipient’s income is invariant to the number 
of units of output produced. By decoupling remuneration from cost drivers, the higher is f and 
the lower is v, and the greater the recipient’s reliance upon income from capitation than upon 
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the number of units of output produced.  The recipient now faces incentives to reduce costs in 
order to increase profitability – for example, producing fewer outputs or finding cheaper ways 
of producing them.  Behavioural change ensues because the undesirable behaviour is no 
longer rewarded, or because the rewards will accrue only by engaging in the desired 
behaviours (Milgrom and Roberts, 1992).   
 
However, capitation contracts have complex effects on practitioner behaviour, as they share 
two specific types of financial risk between the purchaser and the provider: ‘predictable risk’ 
and ‘random risk’.   ‘Predictable risk’ is the responsibility for managing those identified cost-
causing behaviours that are the specific target of the capitation contract, such as a provider 
propensity to order too many treatments, more expensive pharmaceuticals or unnecessary 
laboratory tests (Zeckhauser, 1970), or the use of preventative treatments to improve patient 
health state thereby reducing the number of consultations required (Crampton, Sutton and 
Foley, 2001).  ‘Random risk’ relates to those factors for which the service provider assumes 
either partial or complete financial responsibility via the risk-sharing contract, but is 
powerless to control, such as events that cause an uncontrollable increase in demand for 
consultations (e.g. a localised epidemic) and discrepancies between the ex ante assessment of 
demand for services by the individuals for whom responsibility to deliver care is assumed, 
and their actual demand (‘random’ demand variation).   
 
When a capitation contract shares responsibility for ‘predictable’ risk management between 
the purchaser and the provider, it also shares an equal amount of ‘random’ risk, which also 
affects provider income.  The effects may be either positive or negative, but importantly, they 
are outside the control of the practitioner.  It is therefore crucially important in a capitation 
contract that the amount of financial risk shared is carefully balanced.  The stronger the 
capitation contract incentive (that is, the higher is f and the lower is v), the greater the 
proportion of random risk that is shared, and the more the practitioner’s income comes to 
depend upon random factors that cannot be controlled.  If the ‘random’ effects on the 
practitioner’s income are large compared to the ability to manage income via the 
‘controllable’ factors related to ‘predictable’ risk, then irrespective of the amount of effort 
exerted pursuing the desired activities, the practitioner’s income becomes essentially a 
‘lottery’.  The incentive to pursue the desirable behaviour is ‘crowded out’ and so the desired 
activities are not pursued.  Rather, the practitioner will exert effort instead in activities that 
maintain or increase income given the amount of random risk assumed (e.g. ‘cream-
skimming’ to ensure that the patients for whom care management responsibility is assumed 
are more likely to bring higher fixed income and lower demand for services).  
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Howell (2007) posits that health care capitation contracts pose a particular difficulty in that 
the parties sharing both types of risk- third party insurers and governments – derive their 
justification for undertaking the contracting responsibility in the first place from the fact that 
they are more efficient managers of individuals’ uncertainty in the costs arising from 
uncertain demand for demand for health care services than the individuals themselves (as per 
Arrow, 1963).  When third-party risk aggregators share the responsibility for ‘random’ risk 
that they are charged with managing more efficiently to smaller provider risk pools via 
capitation contracts, the benefits from reduced costs of ‘predictable’ risk must be traded off 
against the increased costs of ‘random’ risk being less efficiently managed than within a 
single large pool.    
 
Moreover, even more caution must be exerted in the case of primary care capitation contracts, 
as the repeated interaction between specific individuals and practitioners leads to serial 
correlation between unknown cost-causing patient characteristics not captured in the 
compensation agreement (e.g. unknown genetic predisposition in an individual) and 
practitioner income.  The consequence is the emergence of habitually profitable and 
habitually loss-making practices (‘lucky’ and ‘unlucky’ respectively).  The greater the amount 
of risk shared (i.e. the higher is f and the lower is v), the greater the difference in profitability 
between the practices of different types, and the greater the propensity for undesirable 
behaviour to be pursued at the expense of desirable behaviour, in order to maintain long-term 
practice financial viability or to maximise profits.   
 
Figure 1 illustrates.  Assume it costs an average practice c to deliver an average primary care 
consultation (including all overheads and a fair return on the human capital and time invested 
by the practitioner).  Average revenue received per consultation is f/q+(v-c). Under a fee-for-
service contract charged at cost (f=0; v=c), the practitioner makes no profits and no losses on 
all consultations delivered (i.e. ‘breaks even’).  The number of consultations delivered is 
independent of q, and is determined solely by the practitioner’s willingness to work.  Under a 
capitation contract, however, the practitioner receives v<c for each consultation delivered.  
There will be a maximum number of consultations that the practitioner will deliver (Q), at 
which point the practice ‘breaks even’.  If ‘luck’ (i.e. demand arising from the actual health 
state of the population for who capitation is received) means that the number actually 
delivered q is less than Q, the practice makes a ‘windfall’ profit.  If luck means q>Q, the 
practice makes real financial losses.   
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Figure 1. Average Revenue Per Consultation: Standard Capitation 
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A capitation contract incentivising desirable behaviours looks for providers delivering more 
than Q consultations through their own choices to reduce the number to Q in order to remain 
financially viable, or for those with costs higher than c to reduce them to c.  However, the 
same contract will financially penalise those practitioners with costs c and not over-
producing, whose ‘luck’, rather than behavioural choices, leads to more than Q consultations 
being delivered.  If these practices are to remain financially viable, they must reduce costs 
below c (e.g. shorter consultations), ration services (e.g. institute waiting lists) or pass the 
extra costs on in some other way (e.g. institute a patient payment y in addition to v).   The 
sharper the capitation contract (i.e. the lower is v and the higher is f), the steeper is the slope 
of the average revenue curve (Figure 1), the greater the profits and losses, and the greater the 
additional costs that must be borne by the patients of ‘unlucky’ practices (q>Q) relative to the 
patients of ‘lucky’ practices (q<Q).  Ironically, these practices are ‘unlucky’ in the first place 
because they have a patient base with higher demand (i.e. ‘sicker than average’), so luck 
combined with the capitation contract leads to sicker-than-average patients bearing more of 
the consequences of ‘luck’, in either lower care quality (shorter consultations, waiting lists) or 
higher prices (y charged to them) than the ‘healthier-than-average patients of ‘lucky’ 
practices.   Howell (2007) notes that budget financing (e.g. as used by government 
departments to finance fully-owned care providers) is simply the extreme case of full 
capitation, where v=0.   
 
Figure 2 illustrates the effect of being able to charge a patient y in order for ‘unlucky’ 
providers to recover the costs of ‘bad luck’.  Assume that the ‘unluckiest’ practitioner not 
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over-producing at cost c must deliver Q1 consultations to meet demand at f and v.  This 
results in the practice making losses of y per consultation.  If the practice charges patients y 
per consultation to break even, the practice will still produce Q1 consultations (technically, 
the practice’s average revenue curve moves upward) as illustrated in Figure 2).  However, if 
one practice can charge y, all other ‘luckier’ practices will also charge y, meaning that the 
average revenue curve of all practices moves upward.  ‘Unlucky’ practices delivering 
between Q and Q1 consultations without charging y now make profits instead of losses, and 
the ‘lucky’ practices producing fewer than Q consultations make higher profits than before.   
The total number of consultations produced is higher than anticipated by the capitation 
contract which was used to set f and v.   However, quality is not compromised.  The cost of 
the additional quality provided (equal to the reduction in quality faced by the patients of 
‘unlucky’ practices if y could not be charged) is the area represented by the additional profits 
plus the losses of the ‘unlucky’ provider in Figure 2.   
    
Figure 2. Average Revenue Per Consultation: Patient pays y 
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In effect, the ability for a capitated provider to charge patients for the costs not met by the 
capitation contract effectively ‘undoes’ the motivation for using financial incentives to alter 
practitioner behaviour in the first place.  If the practitioner can shift the costs of ‘luck’ onto 
the patient, the costs of ‘predictable’ risk can also be shifted.  Financial incentives are 
typically used where the desired behaviour is costly to observe, or direct observation is 
infeasible (as in third-party purchasing).  In such circumstances, the desired changes are 
difficult to induce using non-financial instruments (Milgrom and Roberts, 1992).   Allowing 
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practitioner charging in a capitated contracting environment thus achieves none of the desired 
behavioural changes, and results simply in the total costs of the same number of consultations 
provided being higher than in the case of fee-for-service contracting.   
 
2. The New Zealand Primary Health Care Strategy 
The NZPHCS was introduced in July 2002 (King, 2001).  The key financial instrument is the 
introduction of capitation payments to Primary Health Organisations (PHOs), who then 
contract with primary care providers to deliver services to patients.  Practically all primary 
care providers are paid via a ‘back-to-back’ contract that sees the capitated ‘GMS/Nurse’ 
payment being ‘passed through’ directly to care providers (Howell, 2005).  A key motivating 
factor for the strategy is to increase the share of government funding in the sector from 
between 30% (Austin, 2004) and 40% (King, 2001) in 2001 to around 80% as occurs in the 
secondary and tertiary sectors (Howell, 2007a).   
 
2.1 Service Providers Set and Charge v (plus y)  
The first defining feature of the NZPHCS is that, although the government share of primary 
care sector costs is increasing, patients are still required to pay the balance of costs not 
covered by the government payments to service providers.  That is, whilst the government 
sets and pays f, the service providers set v and the patients pay it.  This arrangement has 
prevailed in New Zealand since 1938, when an agreement between the government and 
service providers allowed service providers to charge patients directly for any costs not 
covered by government subsidies (Ashton, 1999).  This charging arrangement has been 
‘grandfathered’ through into the NZPHCS (Howell, 2005), despite the fact that the 
government payment has changed from an ex post treatment subsidy paid to targeted 
individuals (albeit collected by their service providers on their behalf to defray costs) to an ex 
ante capitation payment made to service providers in recognition of the anticipated (not 
actual) demand of the patients for whom responsibility has been assumed (Howell, 2007a).   
 
In the three years following the introduction of the policy, government funding for primary 
care increased by 43% (Hefford, Crampton and Foley, 2005).  However, the government’s 
total share of expenditure did not increase by as much as the Minister had expected given the 
substantial additional injection of government funding (King, 2004).  From Figure 2, this is 
most likely occurring because loss-making providers have been able to ‘pass on’ the costs of 
risk management to patients.  Whereas the government payments are set using a ‘notional 
averaged variable payment’ v for an average number of consultations Q, most ‘unlucky’ 
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practices have been able to set the patient payment to y+v, passing on the costs of bad luck to 
patients, and avoiding severe financial distress.   
 
Evidence that such practices are occurring and are likely widespread is implied in the 
observation by CBG (2004) that very, early into the operation of the system, providers not yet 
receiving capitation payments for patients were charging less on average for consultations for 
identical patient groups than those providers receiving capitation subsidies.  CBG (2004) 
finds this observation puzzling, but interpreted as per Figure 2, such an observation would be 
expected, as uncapitated practices do not face the costs of ‘random’ effects, as they continue 
to be remunerated under fee-for-service contracts. Furthermore, McAvoy and Coster 
(2005:11) report that “many GPs have already benefited, reporting improved financial 
incomes and financial benefits from joining PHOs”, suggesting both that profits are being 
accrued by ‘lucky’ providers and even ‘unlucky’ providers are avoiding severe financial 
stress by shifting the additional costs of financial risk bearing (both ‘random’ and predictable) 
onto patients.   
 
2.2 Increasing Incentive Strength Over Time 
The second defining feature of the NZPHCS is that the government capitation payments are 
increased over time according to a set of political priorities determined by government 
budgets.  The first beneficiaries were individuals aged over 65 and under 5, and those patients 
registered in PHOs where more than 50% of the registered individuals were in the lowest 
income deciles or of Maori or Polynesian ethnicity (“Access Practices” – the remainder are 
termed “Interim Practices”).  Over subsequent years, higher subsidies were extended to 5-14 
year olds, 15-24 year olds and 45-64 year olds.  The final group, 26-44 year olds, will receive 
higher subsidies from 1 July 2007, by which stage it is anticipated that most differences in the 
funding of Access and Interim practices will be eliminated.   
 
Each capitation increase has also been associated with political expectations that any increase 
in government payments will be directly matched by corresponding reductions in the fees 
charged by practitioners for the subsidy class receiving the more generous government 
assistance.  For example, the Prime Minister stated that the July 1 2006 capitation increases 
meant that “700,000 people aged between 45 and 64 would now pay $27 less for doctor visits 
and $3 for prescriptions – instead of $15 – if they enrolled with a primary health 
organisation”1.  Despite more groups becoming higher-capitated, there is still an expectation 
                                                     
1 http://www.stuff.co.nz/stuff/0,2106,3719646a7144,00.html 
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that some groups will continue to pay different patient payments based on class membership – 
for example, there is strong pressure for practitioners not to charge a fee for consultations 
delivered to children under 5 years old.  This group commands the highest capitation 
payments, but generates the greatest demand.  DHB and MoH policy material supports the 
contention that this approach to fee setting is expected for price monitoring and if necessary, 
price regulation (DHB, 2006).  
 
The overall effect of this requirement is that, over time, the average amount of a practitioner’s 
income that comes from government subsidies (f) increases and the share from patient 
payments (v) decreases.  The capitation incentive strength thus becomes increasingly sharp 
each time the government includes another group of the population amongst the higher-
capitated (as per Figure 1).  At each increase, the share of both ‘predictable’ and ‘random’ 
financial risk that practitioners are required to bear becomes greater.   United States evidence 
suggests that the amount of primary health care demand variation that can be reliably be 
predicted using individual characteristics such as age, gender, past health consumption, 
income and ethnicity is between 20% and 25% (Newhouse, 1006; Robinson, 2004).  Ma and 
Riordan (2002) report that significant practitioner behavioural changes have been evidenced 
in the case of contracts with very weak capitation incentives.  Yet, the New Zealand contracts 
will ultimately see practitioners facing extremely strong incentives, where 80% of their 
income is fixed, and only 20% comes from patients.  That is, the income earned from 
delivering an additional consultation will be only 20% of the cost of delivering it.   
 
2.3 Implications 
The NZPHCS is paying practitioners using a capitation instrument, but is requiring 
practitioners to charge different levels of v for each subsidy group depending upon the level 
of the capitation subsidy paid.  Whereas on the one hand, capitation contracts are paying 
‘insurance premium subsidies’ to insurer-managers to manage individual demand risk, on the 
other hand, practitioners are required to charge patients as if the government payments are 
‘notional averaged treatment subsidies’ as occurred under the previous fee-for-service system.   
These arrangements take no cognisance of who will bear the additional risk management 
costs imposed by the system design.   
 
The peculiar charging arrangements and political expectations limit the ability for 
practitioners to ‘average out’ the differences in demand facing the practice by using ‘gains’ 
from lower-than-expected demand from one subsidy group to cross-subsidise higher-than-
expected demand from another subsidy group.  The result is that the effects of ‘random risk’ 
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are being shared not simply with 4000 practitioner pools of 1200 to 2000 patients, but with up 
to 48 different patient pools within each practice pool (Howell, 2005).  Any of the benefits of 
aggregated management of individual demand uncertainty via a centralised risk management 
(insurance) pool has effectively been dismantled.  
 
As illustrated in Figures 1 and 2, and discussed above, the random risk component is almost 
certainly being passed onto patients in the form of higher patient payments, with much of the 
additional government subsidies being extracted by providers in the form of profits largely 
resulting from ‘luck’.  However, the allocation of the additional costs of the system is quite 
inequitable, as it results in those patients potentially most in need of care facing a greater 
share of the additional out-of-pocket or care quality reduction costs.   Moreover, the 
additional risk management costs are borne in proportion to the health state of the individual.  
Someone who is frequently ill must make more visits, so pays a greater number of payments 
towards the additional risk management costs than a less frequently ill individual.  Indeed, 
those who make no doctors visits pay none of the additional risk management costs, despite 
receiving the benefit of a reduced expected cost of treatment if, in the future, care is required.   
 
The overall effect is a primary health care system that is likely very much more costly than 
the pre-2002 counterfactual, with a very inequitable allocation of the additional costs, due to 
the dismantling of any centralised patient demand risk management instruments.  It will also 
be unable to utilise financial incentives to achieve any of the practitioner behavioural changes 
articulated in the policy, such as an increased emphasis on preventative care, as the ability to 
pass through costs to patients removes any ability to control practitioner behaviour by 
constraining practitioner incomes.  Whilst price controls may limit the ability to pass through 
risk management costs, such actions will simply accelerate the effects of inequitable 
allocation of resources by forcing a reduction in the number of consultations provided, and 
the conversion of the additional financial costs currently being accrued into reduced care 
quality for those most likely to need multiple consultations.   
 
3. Illustration by Stylised Examples  
This section uses a few stylised examples based on actual events to illustrate the effects of the 
allocation of random risk under the New Zealand arrangements as discussed in Sections 1 and 
2.   The first examples take a truly ‘random’ shock to demand facing a primary care practice –  
a strike by hospital junior doctors and the decision by District Health Boards to ‘cull’ hospital 
waiting lists by requiring all individuals unable to be seen by a hospital provider within six 
months to be removed from waiting lists and referred back to general practitioners for 
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management.  These examples show that ‘luck’ is not just confined to the initial allocation of 
patients amongst practices, but that the New Zealand arrangements also spread the cost of 
other ‘bad luck’ unequally amongst practices and patients.  The second set of examples 
illustrates the perverse allocative effects of the translation of capitation payments by 
government into ‘notional averaged treatment subsidies’ for the purpose of setting and 
regulating patient charges.  Such an arrangement ignores how a practitioner will allocate the 
costs of risks that are unable to be controlled by clinical practice amongst the balance of the 
patient base.  These examples illustrates how a change in capitation payments will necessarily 
be associated with cost increases for those patient groups not receiving capitation increases, 
reflecting how the risks are now shared amongst very small patient pools (the practice) rather 
than larger pools as would occur with a centralised risk manager.   
 
3.1  Doctors’ Strike/Waiting List Cull 
The recent junior hospital doctors’ strike and implementation the policy to remove all patients 
unable to be seen by hospital specialists in less than six months from hospital waiting lists 
represent ‘random’ events not foreseen by either party when the original capitation contract 
was agreed.  In both of these instances, the patients whose demand for hospital services was 
unable to be met in the tertiary system were referred back to their primary care providers for 
treatment.  These policies thus comprise a ‘shock’ to demand for primary care services.  Each 
patient referred back by the DHB would require at least one, but presumably several, 
additional primary care consultations that the practitioner would be unable to avoid providing, 
relative to the number that would have been provided had the patients been treated at the 
hospital.   
 
Such ‘uncontrollable’ increases in demand impose the full costs of the additional 
consultations upon providers.  Under fee-for-service, practitioners would be indifferent to 
such an event or policy change.  Under capitation, however, a practice incurs the full costs of 
an additional consultation, but receives no additional government payments.  Moreover, as the 
capitated patient is charged a fee less than cost (v < c), the additional income will be 
insufficient to cover the additional costs of the unanticipated consultations.  The practice now 
incurs a deficit in respect of the additional demand.  The deficit can be covered in one of three 
ways: by passing on the costs to patients via higher patient charges, reducing total costs by 
shortening all consultations, or by ‘cream-skimming’ – for example, refusing to treat DHB-
referred patients or declining to register patients who are likely to need hospital treatment in 
the future, and might be subject to delays in receiving this treatment due to the vicissitudes of 
the hospital systems.  
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 3.1.1 The Base Case 
Assuming that consultation time reduction and patient cream-skimming are initially 
eschewed, the only option left is to raise fees (patient payment = v+y).  A simple numerical 
example illustrates.  Suppose each consultation costs the practice $50, and the patient 
payment (v) is initially set at $20.  Each additional patient referred back by the DHB imposes 
a $30 deficit on the practice.  The more patients referred back by the DHB, the greater the 
number of consultations, and the greater the deficit incurred.  The practice can break even 
only by charging the additional costs to all patients via an increased patient payment y.  All 
patients now pay the risk premium.  Practices with more, and sicker (i.e. requiring multiple 
consultations), patients referred back must charge their patients more (i.e. more payments of y 
each are required) to recoup costs than those with fewer patients referred.  If higher patient 
charges cannot be levied, then the costs are incurred as reductions in service quality, with the 
patients of the ‘unluckiest’ practices (i.e. those with more patients ort higher-need patients 
referred back) receiving the greatest reduction.  
 
Thus, all sick patients will pay more at the GP’s surgery to meet the costs of risk and demand 
shifting imposed by the DHB referral policy, but the patients of GPs with more and sicker 
patients referred back will pay proportionately more of the costs of the DHB policy.  Note 
that well individuals pay none of the additional costs of the policy, as they make no GP visits.  
This is in direct contrast to the pre-2002 system, when all individuals, sick or well, shared the 
additional costs of a reallocation of the demand of a subsidised individual between the tertiary 
and primary sectors, via taxes covering the increased number of treatment subsidies paid. 
 
3.1.2 Different Capitation Classes and Patient Charges 
Now consider the effects of the mandatory requirement that individuals for whom higher 
capitation payments are received when well must also pay commensurately lower patient 
payments when, they fall ill and seek a primary care consultation.  Assume the practice in the 
base case charges high-capitated over 65 year-old patients $15 per consultation, and low-
capitated 25-44 year-old patients $48 per consultation.  The deficit for each additional DHB-
referred over-65 consultation is $35 and for each additional 25-44 consultation $2.  The 
higher the proportion of higher-capitated (ex ante assessed as ‘high needs’ or ‘high political 
priority’) patients referred back under the DHB policy, the greater the deficits incurred by 
practices and the higher the commensurate price increases to all patients must be.  The 
patients of practices with large numbers of higher-capitated patients referred back will pay 
proportionately more of the cost of the DHB policy than those of the practices with fewer 
higher-capitated patients referred back.   
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 The costs of the DHB waiting list cull, in particular, are unlikely to be trivial.  Typically, 
higher-capitated elderly and young people are disproportionately represented in hospital 
waiting lists. Thus, the probability of a waiting list patient referred being a high-capitation 
individual will be substantially higher than the probability of the patient being a low-
capitation individual.  These individuals are also likely to require multiple additional primary 
care consultations in order to continually treat the waiting list condition and to reassess the 
eligibility for re-entry into the waiting list system.  These non-trivial additional costs, imposed 
by the DHBs shifting demand and financial risk into the primary sector, will have a non-
trivial effect upon the costs paid by all sick individuals seeking primary care.   
 
This example illustrates the problem of treating the capitation subsidy as if it is a ‘notional 
averaged treatment subsidy’ when setting v for each subsidy group.  Government capitation 
payments are paid ex ante in respect of all individuals, irrespective of their actual demand for 
care.  Treatment subsidies are paid ex post in respect of individuals who have fallen ill and 
need treatment.  Whilst a capitation subsidy can be mathematically averaged out to create a 
‘notional average treatment subsidy’, this will match a patient’s actual demand only if the 
individual consumes exactly the amount of care expected in the average payments.  Each 
patient receiving treatment may have an identical need for treatment, but the government 
payment is confusing a risk-rated insurance premium subsidy, as occurs with a capitation 
payment ex ante, with a socially-motivated wealth transfer when requiring an equally ill 
individual of a different subsidy class to pay a different patient payment ex post, as was the 
case pre-2002 when the government payment was a targeted treatment subsidy transferring 
wealth from the whole population to targeted individuals.   
 
In the NZPHCS, risk management costs become bundled in with wealth transfers when the 
number of consultations consumed by each subsidy class differs, for genuine, random risk-
related reasons, from the anticipated number used to set the ‘notional averaged treatment 
subsidy’.  The result is that individuals will pay different amounts based upon practice risk 
characteristics, and that the direction of the payment size may be opposite to that intended by 
the wealth transfer.  The ‘solution’ clearly is to separate risk management from wealth 
transfers by making the payments for patients receiving identical care (e.g. zero, as in 
England’s NHS, or a standard fee for each patient receiving identical Accident Compensation 
Corporation -funded treatments from the same providers) with the distributional effects of 
wealth transfers being accounted for at the point of subsidy (i.e. all individuals receive a 
capitation premium subsidy, so all individuals should contribute a top-up ex ante to ensure 
that the risk management costs are shared equally).   
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 For example, extending the ACC analogy, a forester and an office manager both pay the same 
patient payment at the GP for treatment for an identical injury, even though the forester’s 
employer pays a higher (risk-rated) premium subsidy ex ante.  The forester and the clerk both 
‘top up’ the costs of the ACC liability via income-related premium top-ups paid as payroll 
taxes.  Wealth transfers (from high-income office managers to low-income foresters) and risk 
management (risk-rated premiums reflecting higher anticipated injury rates for foresters) both 
occur at the point of the subsidy payment, meaning that further wealth transfers do not need to 
be made at the point of treatment (although if the ACC payment is less than the provider’s 
costs, they may both have to make an identical payment to the provider to meet the total fee 
charged).  Thus, health/injury state does not get confused with either risk management or 
wealth transfers when ex post when each individual has an equal claim on the available 
treatment resources (i.e. injured clerks do not have to pay more simply because more than the 
average number of foresters is injured, whilst uninjured clerks and foresters pay nothing at all, 
as is the (translated) case under the NZPHCS).    
 
3.1.3 Patient List Mix 
Assume now that one practice has a high proportion of individuals ‘on the books’ assessed as 
eligible for more generous capitation subsidies because they exhibit the ex ante characteristics 
deemed more likely to result in higher consultation demand (Practice A), and another practice 
(Practice I) has a low proportion.  Practice A thus receives a higher proportion of its revenue 
from fixed payments, and it can only charge its patients on average low values of v.  Practice I 
receives a lower proportion of its income from fixed payments, and more from patient 
payments (i.e. v is higher).   
 
Both practices provide the same number of consultations (K) in a given period.    The average 
patient payment v at Practice A is $20 per consultation, and at Practice I $35.   Assume also 
that, as a consequence of the DHB patient referral policy, each is required to provide an 
additional 200 consultations in a given period.  Practice A incurs a deficit of 200 x $30 = 
$6000, and Practice I a deficit of 200 x $15 = $3000.  If each practice spreads the additional 
costs across all patients, Practice A patients will pay an additional $6000/(K+200), twice the 
increase faced by Practice I patients, $3000/(K+200).  Thus, the DHB referral policy results in 
the ex-ante assessed ‘higher need’ Practice A patients, who are deemed less able to meet the 
costs of higher patient payments, and more likely to be dissuaded from seeking primary care 
by the size of the co-payment, and ostensibly more likely to need care in the first place, facing 
higher patient payment increases than the ‘lower priority’ Practice I patients. 
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This example illustrates numerically the greater risks to financial viability posed by sharper 
incentives.  Practice A faces a sharper incentive contract than Practice I.   The financial costs 
of a random shock are much greater under sharper incentives.  It also illustrates the wealth 
transfer inequities resulting from treating ex ante premium subsidies with ex post treatment 
benefits when setting patient payments. These are not equivalent as a consequence of random 
risk elements.  This example shows the inequitable effects if the ex ante premium subsidy is 
actually a fair reflection of actual demand.  
 
3.1.4 Regulatory Intervention in Practice Price Setting 
It now becomes clear how critically important the ways in which primary care patient charges 
will be regulated under the New Zealand capitated system become.  Unless regulators are 
fully informed about all of the components leading to changes in patient out-of-pocket 
payments levied in all capitation classes by all providers, naïve price controls threatening the 
financial viability of practices may be imposed, accelerating the development of a two-tier 
system differentiated on patient risk, care quality and ownership.    
 
Under the capitated system, if price changes are regulated as if they are still solely performing 
the role of topping up a ‘notional average treatment benefit’ per consultation without taking 
account of changes in financial risk for ‘random’ effects, then regulators may unwittingly 
prevent the fair recouping by practitioners of legitimate additional costs of the capitated 
system in order to maintain financial viability.  DHB materials and politicians’ expressed 
intentions suggest that neither group fully appreciates how the capitated system has shifted 
substantial amounts of additional random risk costs onto practices relative to the pre-2002 
system.  There is consequently substantial additional regulatory risk in the New Zealand 
system that ‘naïve’ price regulation might impact adversely upon the ongoing financial 
viability of general practices.  Thus, it is not surprising that GPs have expressed significant 
concerns about the prospect of being subject to price regulation by DHBs under the currently-
voiced understandings2. 
 
Assume now that a naïve regulator, knowing that Practice A receives higher capitation 
payments, and therefore, in line with treatment benefit pass-through expectations, must 
charge lower patient out-of-pocket payments than Practice I, is faced with the price rises in 
example 3.1.3 above.   If the regulator presumes that the capitation payment is simply a 
‘notional averaged treatment subsidy’, then the price increase of $6000/(K + 200) imposed by 
                                                     
2 See, for example, GP Leaders’ Forum.  2006.  Auckland GP meeting told to reject govt plan.    
http://scoop.co.nz/stories/GE0605/S00162.htm
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Practice A is ‘unreasonable’ given that Practice I with the same demand increase imposes a 
price increase of only  $3000/(K + 200).  If the regulator restricts the price increase by 
Practice A to that imposed by Practice I, then Practice A becomes financially unviable.   
 
Clearly, in a capitated system it is quite inappropriate to treat capitation subsidies as ‘notional 
averaged treatment subsidies’ for the purposes of either setting patient payments or the pursuit 
of equity based on actual health state.   
 
3.2 Selective Capitation Payment Increases  
The potential for naïve imposition of price regulations in the absence of detailed 
understanding about the allocation of ‘random’ and ‘predictable’ risk is further illustrated by 
the consequences of requiring increases in capitation payments paid in respect of well 
individuals (f) to be passed through directly as commensurate decreases in patient payments 
for individuals seeking treatment (v).  Assume that a practice has 1000 patients.  For 
simplicity, assume that initially, none are subsidised via capitation; however the same effect 
will apply to all patients not included in each capitation increase, including those already 
highly-capitated.  The practice charges $50 per consultation, which equals costs (including a 
fair return on investment).  On average, each patient makes 4 visits a year (4000 
consultations).  Practice costs are $50 x 4000 = $200,000. 
 
Assume now that half the patients (Group Y) are provided a capitation ‘subsidy’ of $100 per 
year.  The remainder (Group X) are funded as before.  The capitation funder requires that the 
practice reduce the patient charges for Group Y to $25 per consultation.  On past 
consumption, this would appear, on average, to be fiscally neutral for the practice.  However, 
as Group Y patients now pay less than the full cost of a GP treatment, they increase their 
consumption to five visits per year as a consequence of paying lower prices.  Whilst some of 
the increased demand may be for justifiable medical conditions, some will be increased moral 
hazard over-consumption by the ‘worried well’.   
 
As a consequence of the increased consumption, the practice costs now increase to $40 x 
4500 = $225,000 per annum.  Group Y patient payments yield $25 x 2500 = $62,500, which 
added to the capitation income contributes $112,500 to the practice’s income.  As Group Y 
charges are capped at $25, the practice must recoup all other costs from Group X patients.  
The Group X patient payment is now $112,500/2000 = $56.25 per consultation.  The 
capitation pass-through requirement for Group Y patients means that the patient payment for 
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Group X patients, who receive no subsidy increase, will rise in order to pay for the increased 
consumption of the newly-subsidised.   
 
This example further illustrates how sensitive any price regulation in the capitated system 
must be to the trade-offs between random and predictable risk.  Even though allowances may 
be made in the price regulations for some extent of increased consumption it is extremely 
difficult for a regulator to ascertain the different likelihoods of patients in different practices, 
or even within different capitation categories in the same practice, to alter their demands in 
response to marginal changes in patient payments.  Two practices with identical patients in all 
other respects may levy different price changes in response to changes in capitation payments 
because one has more ‘worried well’ on the books than the other.  As price regulation will 
prevent any shifting of these patient-induced costs on in patient charges, they become a cost 
to the practice and a risk to its ongoing financial viability.  Selectively increasing patient 
subsidies increases practice costs, so must be considered when setting incentive strengths if 
the outcome is going to raise efficiency, and when regulating prices in order to maintain 
practice financial viability.     
 
Given that over half the population received no treatment subsidies pre-2002, there must be 
considerable uncertainty about their propensity to over-consume when provided with what 
appears to them in the perspective of their experience as notional treatment subsidies (reduced 
out-of-pocket payments) under the capitated system.  International evidence suggests that 
over-consumption by the worried well is substantially more likely to occur amongst higher-
income and higher-educated individuals than amongst lower-income, less well-educated ones 
(Shen and McFeeters, 2005).   As income was the primary determinant of subsidy provision 
pre-2002, it is likely that the progressive inclusion of high-income individuals in the capitated 
system will result in substantial additional consumption costs that, ironically, must be 
imposed on the already-capitated higher-priority individuals if regulators impose price 
restrictions under pass-through expectations that do not reflect the true extent of additional 
demand generated.   
 
The ‘regulation’ examples provide a very cogent illustration why full understanding of both 
the insurance and health care aspects of health systems must necessarily underpin both their 
design and their regulation.  Unless regulators and policy-makers are fully cognisant of all of 
the factors that may affect prices in every practice, and recognise that each practice may face 
a unique set of risks due to its diverse allocation of patient demands and system expectations, 
it becomes extremely difficult to apply any meaningful form of price regulation.  Rather, 
considerable regulatory risk and potential sector distortion is introduced.  
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 International evidence suggests that regulation of capitated systems is fraught with difficulty.  
Even in the case of very mature health insurance markets in the United States, the complexity 
imposed by risk-sharing contracts imposes insurance responsibilities upon individual 
practices that makes effective price regulation problematic (Hagen, 1999).  It is unlikely that 
the task would be any easier in New Zealand.  Furthermore, it is highly unlikely that twenty 
one individual New Zealand DHBs, more experienced in the provision of hospital care and 
contract management than health insurance management and regulation, would be as 
informed and as experienced, and therefore as capable of undertaking the regulatory task as 
specialist health insurance regulators such as Hagen.   Indeed, Ashton (1999) indicates that a 
fundamental reason why the government chose not to proceed with the creation of competing 
health care insurers as proposed in the Green and White Paper (Upton, 1990) but instead 
formed four regional funding monopolies in 1994 related to the potential efficiency and 
equity consequences and the difficulties of operating and regulating competing private sector 
health insurers.   
 
4. Conclusion 
This paper has illustrated both in theory and in stylised examples that extreme care must be 
taken when designing capitation contracts in primary care markets that the effects of ‘random’ 
and ‘predictable’ risk are traded off against each other in a way that ensures that the effects of 
random risk do not crowd out the desired behavioural changes.  Moreover, the paper shows 
that the design of health systems using capitation contracts must take great care to ensure that 
other elements in the design of the system do not impede the ability of the capitation contract 
to achieve its principal aims. 
 
The NZPHCS arrangements provide an example where the effects of random risk appear to 
have been assumed away, with the consequence that the resulting system, based upon 
capitation payments to service providers, will achieve neither the desired behavioural changes 
nor the equity objectives of the strategy.  Whilst increased government funding has reduced 
out-of-pocket costs for patients, total system costs have undoubtedly risen relative to a fee-
for-service counterfactual, with the burden of extra costs falling disproportionately on the 
most frequently ill.  Moreover, the vulnerable individuals for whom the system was supposed 
to provide greater benefits, are also disproportionately affected by other any policy changes 
that affect the demand for general practitioner services.  The costs of ‘random’ risks such as 
the waiting list cull are certainly being paid at the GP’s surgery, with the sickest paying most 
of these costs, and the habitually well reaping the benefits.   
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